Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021
Cash and cash equivalents
Restricted cash	$ 2,207	$ 525
Securities purchased under resale agreements	476	463
Accumulated depreciation and amortization	8,907	8,602
Other assets, reserves for credit losses	22	25
Liabilities
Long-term debt	$ 38,337	$ 38,675
Shareholders’ Equity
Preferred shares, par value (in dollars per share)	$ 1.667	$ 1.667
Preferred shares authorized (in shares)	20,000,000	20,000,000
Preferred shares, issued (in shares)	1,600
Preferred shares, outstanding (in shares)	1,600
Common shares, par value (in dollars per share)	$ 0.20	$ 0.20
Common shares, authorized (in shares)	3,600,000,000	3,600,000,000
Common shares, issued (in shares)	755,000,000	761,000,000
Common shares, outstanding (in shares)	755,000,000	761,000,000
Card Member Receivables
Cash and cash equivalents
Financing receivables, gross	$ 53,164	$ 53,645
Allowance for credit losses	76	64
Card Member Loans
Cash and cash equivalents
Financing receivables, gross	88,832	88,562
Allowance for credit losses	2,981	3,305
Other Loans
Cash and cash equivalents
Allowance for credit losses	48	52
Variable Interest Entity, Primary Beneficiary
Cash and cash equivalents
Restricted cash	8	11
Restricted investments	1,745	32
Liabilities
Long-term debt	11,788	13,803
Variable Interest Entity, Primary Beneficiary | Card Member Receivables
Cash and cash equivalents
Financing receivables, gross	5,640	5,175
Variable Interest Entity, Primary Beneficiary | Card Member Loans
Cash and cash equivalents
Financing receivables, gross	$ 26,017	$ 26,587